You might think that an official rebuke of Pfizer’s CEO for misleading the public on the benefits of its Covid vaccine would be big news. But even with a Google search, I have not yet seen any US media coverage of a starling criticism by a panel convened by the UK Prescription Medicines Code of Practice Authority (PMCPA).